Condition
Pick Disease of the Brain
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (2)
P 2 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04937452Phase 2Completed
Dopaminergic Therapy for Frontotemporal Dementia Patients
NCT00674960Phase 1UnknownPrimary
Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
NCT00077896Phase 1CompletedPrimary
Direct Current Brain Polarization in Frontotemporal Dementia
Showing all 3 trials